Pelago stock

Pelago Stock

HealthTech
Founded: 2017Funding to Date: $138Mhttps://www.pelagohealth.com

Pelago operates a behavioral therapy platform designed to empower individuals in overcoming addictions. The platform utilizes cognitive behavioral therapy to address the psychological aspects of addiction, helping users identify their triggers. Through animated videos, interactive exercises, and audio sessions, Pelago provides support to users, enabling them to tackle their addictions at their own pace. The platform offers a personalized coach, assisting users in their journey to recovery.

Investors Include:

Serena Ventures, Octopus Ventures, SemperVirens Venture Capital, Pioneer Fund, Force Over Mass Capital, GreyMatter Capital, Ariel Poler, Lionheart Ventures, AAF Management, Eight Roads, DigitalHealth.London Accelerator, Elevation Capital (Canada), EQT Ventures, Vishal Gulati, Venus Williams, Merck & Co., Telefónica, Kyle Hendrick, Atomico, Cur8 Capital, Mentors Fund, Kinnevik, Damien Marmion, Triple Point, Max Mullen.

Own Pelago stock or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure

Management Team

Sarim Siddiqui MDCo-Founder & President
Maroof Ahmed MDCo-Founder & Chief Operating Officer
Yusuf Sherwani MDCo-Founder, Chief Executive Officer & Board Member
Chad EgelhoffSenior Director of Demand Generation
Steven WhiteRegional Vice President, Health Plan Sales
Anmol Madan Ph.DAdvisor
Ingrid KesslerChief People & Administrative Officer
Edward DaleyChief Commercial Officer
Dana LettreVice President of Strategic Sales
Jay HelmerVice President, Health Plan Partnerships
Michael ReiffChief Product Officer
DeVonne MowryVice President, Finance
Corrissa DodaVice President of Sales & Large Market / DEI Committee Member & Advocate & Regional Sales Director
Sheeraz IqbalCo-Founder
Paige SwanepoelChief Marketing Officer
Suzette Glasner Ph.DChief Scientific Officer

Board Members

William GibbsBoard Member
Laura ConnellBoard Member

Pelago’s stock FAQs

Other HealthTech Companies in Collective's mid-stage Target Portfolio.

A2 Bio stock
Aardvark Therapeutics stock
AcuityMD stock
Alamar Biosciences stock
Alterome Therapeutics stock
Arbor Biotechnologies stock
Attralus stock
Be Biopharma stock
Bluejay Therapeutics stock
Brightside Health stock
Capstan Therapeutics stock
Carrum Health stock
Casana stock
Cellanome stock
Centivo stock
Chroma Medicine stock
Conformal stock
Convergent Therapeutics stock
Covera Health stock
Detect stock
Dewpoint Therapeutics stock
Dispatch Biotherapeutics stock
Egenesis stock
Elektrofi stock
Engrail Therapeutics stock
Equip stock
Firefly Health stock
Flare Therapeutics stock
Florence stock
FogPharma stock
Foresight Mental Health stock
Frontier Medicines stock
Genesis Therapeutics stock
Graviton BioScience stock
Hexagon Bio stock
Iambic Therapeutics stock
IDRx stock
Inceptive stock
Infinitus Systems stock
KSQ stock
Levels stock
LifeMine stock
LightForce stock
Loyal stock
Luna Physical Therapy stock
Lycia Therapeutics stock
Marea stock
Medallion stock
Nalu Medical stock
Neuron23 stock
NextPoint stock
OrsoBio stock
Ossium Health stock
Ostro stock
Overjet stock
Pager stock
Paradigm stock
Paradromics stock
Pathalys Pharma stock
Pomelo Care stock
Rad AI stock
ReCode Therapeutics stock
Regard stock
Rivus Pharmaceuticals stock
Route 92 stock
SalioGen Therapeutics stock
Santa Ana Bio stock
Seismic Therapeutic stock
Sionna stock
SmarterDx stock
SmithRx stock
Strand Therapeutics stock
Suki stock
Syllable stock
Synchron stock
Synthekine stock
Third Arc Bio stock
Tome Biosciences stock
Tomorrow Health stock
Triveni Bio stock
Two Chairs stock
Unlearn stock
Vanqua Bio stock
Verse Medical stock
Viome Life Sciences stock
Vizgen stock